Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Vicagrel vs clopidogrel in ACS patients undergoing PCI
CTR20242930Phase 3Active
- Sponsor
- Wecare Probiotics
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vicagrel in acute coronary syndrome (ACS), myocardial infarction (MI), ischemic stroke, arteriosclerosis obliterans, sponsored by Wecare Probiotics. Started Sep 2024; status: active.
02
Drugs
vicagrel
03
Conditions
acute coronary syndrome (ACS)myocardial infarction (MI)ischemic strokearteriosclerosis obliterans
Beyond the preview
Go deeper on CTR20242930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242930.